ID

25667

Descrizione

Study ID: 101468/228 Clinical Study ID: 101468/228 Study Title:A two year Phase IIIb randomised, multicenter, double-blind, SINEMET controlled, parallel group, flexible dose study, to assess the effectiveness of controlled release ropinirole add-on therapy to L-dopa at increasing the time to onset of dyskinesia in Parkinson's disease subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00363727 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Dyskinesias; Parkinson Disease; Parkinson's Disease Study part: Study conclusion.

Keywords

  1. 2017-08-25 2017-08-25 -
  2. 2017-09-08 2017-09-08 -
Caricato su

8 september 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :


Non ci sono commenti

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Study conclusion GSK study Dyskinesia in Parkinson's disease NCT00363727

Study conclusion GSK study Dyskinesia in Parkinson's disease NCT00363727

General information
Descrizione

General information

Protocol identifier
Descrizione

Protocol identifier

Tipo di dati

integer

Alias
UMLS CUI [1]
C2826693
Subject Identifier
Descrizione

Subject Identifier

Tipo di dati

text

Alias
UMLS CUI [1]
C2348585
Visit Description
Descrizione

Visit Description

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0545082
UMLS CUI [1,2]
C0678257
Pregnancy information
Descrizione

Pregnancy information

Did the subject become pregnant during the study?
Descrizione

If Yes, complete Pregnancy Notification form.

Tipo di dati

text

Alias
UMLS CUI [1]
C0032961
Study conclusion
Descrizione

Study conclusion

Date of subject completion or withdrawal
Descrizione

Date

Tipo di dati

date

Alias
UMLS CUI [1]
C0011008
Was the subject withdrawn from the study?
Descrizione

Withdrawal

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C1519255
If Yes, check the primary reason for withdrawal:
Descrizione

reason withdrawal

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C0392360
If other reason, specify
Descrizione

other reason withdrawal

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C1519255
UMLS CUI [1,3]
C3840932
Investigator comment log
Descrizione

Investigator comment log

CRF page number if applicable
Descrizione

CRF page number

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0237753
UMLS CUI [1,2]
C1516308
UMLS CUI [1,3]
C1515022
Comment
Descrizione

Comment

Tipo di dati

text

Alias
UMLS CUI [1]
C0947611
Investigator's signature
Descrizione

Investigator's signature

Investigator’s Signature
Descrizione

Investigator Signature

Tipo di dati

text

Alias
UMLS CUI [1]
C2346576
Date
Descrizione

signature date

Tipo di dati

date

Alias
UMLS CUI [1]
C0807937
Investigator’s name (print)
Descrizione

Investigator name

Tipo di dati

text

Alias
UMLS CUI [1]
C2826892

Similar models

Study conclusion GSK study Dyskinesia in Parkinson's disease NCT00363727

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
General information
Protocol identifier
Item
Protocol identifier
integer
C2826693 (UMLS CUI [1])
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Visit Description
Item
Visit Description
text
C0545082 (UMLS CUI [1,1])
C0678257 (UMLS CUI [1,2])
Item Group
Pregnancy information
Item
Did the subject become pregnant during the study?
text
C0032961 (UMLS CUI [1])
Code List
Did the subject become pregnant during the study?
CL Item
Yes (Y)
C0549206 (UMLS CUI-1)
(Comment:en)
CL Item
No (N)
C0232973 (UMLS CUI-1)
(Comment:en)
CL Item
Not Applicable (not of childbearing potential or male) (x)
C1272460 (UMLS CUI-1)
(Comment:en)
Item Group
Study conclusion
Date
Item
Date of subject completion or withdrawal
date
C0011008 (UMLS CUI [1])
Withdrawal
Item
Was the subject withdrawn from the study?
boolean
C2349954 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Item
If Yes, check the primary reason for withdrawal:
text
C2349954 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Code List
If Yes, check the primary reason for withdrawal:
CL Item
Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate) (1)
C0877248 (UMLS CUI-1)
(Comment:en)
CL Item
Lost to follow-up (2)
C1302313 (UMLS CUI-1)
(Comment:en)
CL Item
Protocol violation (3)
C1709750 (UMLS CUI-1)
(Comment:en)
CL Item
Subject decided to withdraw from the study (4)
C2348571 (UMLS CUI-1)
(Comment:en)
CL Item
Lack of efficacy (5)
C0235828 (UMLS CUI-1)
(Comment:en)
CL Item
Sponsor terminated study (6)
C1710224 (UMLS CUI-1)
(Comment:en)
CL Item
Dyskinesia (28)
C0013384 (UMLS CUI-1)
(Comment:en)
CL Item
Other (Z)
C0205394 (UMLS CUI-1)
(Comment:en)
other reason withdrawal
Item
If other reason, specify
text
C2349954 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
C3840932 (UMLS CUI [1,3])
Item Group
Investigator comment log
CRF page number
Item
CRF page number if applicable
integer
C0237753 (UMLS CUI [1,1])
C1516308 (UMLS CUI [1,2])
C1515022 (UMLS CUI [1,3])
Comment
Item
Comment
text
C0947611 (UMLS CUI [1])
Item Group
Investigator's signature
Investigator Signature
Item
Investigator’s Signature
text
C2346576 (UMLS CUI [1])
signature date
Item
Date
date
C0807937 (UMLS CUI [1])
Investigator name
Item
Investigator’s name (print)
text
C2826892 (UMLS CUI [1])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial